Related Experiment Video
Updated: Apr 21, 2026

18:57
Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers
Published on: October 17, 2013
45.7K
[Transportation medicine--experience, problems, prospects, right for recognition].
Meditsina Truda I Promyshlennaia Ekologiia
|October 23, 2014
Summary
Chronic non-infectious diseases significantly impact driver health and road safety. A lack of research highlights the need for traffic medicine development in the Russian Federation.
Area of Science:
- Road safety
- Occupational health
- Public health
Context:
- Analysis of Russian and international research on driver health.
- Focus on chronic non-infectious diseases and their link to driving impairment.
- Examination of traffic accident frequency and outcomes.
Purpose:
- To establish the foundation for recognizing traffic medicine in the Russian Federation.
- To highlight the critical need for scientific and practical projects in this domain.
Summary:
- Review of key publications reveals a significant link between chronic diseases in drivers and impaired driving performance.
- Existing research and practical projects in traffic medicine are insufficient.
- This gap necessitates the formal acknowledgment and development of traffic medicine.
Impact:
- Provides a rationale for establishing traffic medicine as a distinct field in Russia.
- Aims to improve road safety by addressing driver health issues.
- Encourages further research and practical interventions in traffic medicine.
More Related Videos
Related Concept Videos
Carrier-Mediated Transport
1.5K
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
1.5K
Routes of Drug Administration: Overview
8.8K
Drug administration involves delivering drugs to the body through various routes, such as enteral, parenteral, and topical.
Enteral administration refers to drugs absorbed through the gastrointestinal tract. They can be swallowed (perorally), placed under the tongue (sublingually), or on the inner lining of the cheeks (buccally). Perorally administered drugs take time to be absorbed and have a slower onset of action. The rectal route is another form of enteral administration, which allows for...
Enteral administration refers to drugs absorbed through the gastrointestinal tract. They can be swallowed (perorally), placed under the tongue (sublingually), or on the inner lining of the cheeks (buccally). Perorally administered drugs take time to be absorbed and have a slower onset of action. The rectal route is another form of enteral administration, which allows for...
8.8K
ABC Transporters: Exporter
5.6K
ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
5.6K
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
394
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
394
Hepatic Drug Clearance: Role of Transporters
383
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
383
Short-distance Transport of Resources
14.4K
Short-distance transport refers to transport that occurs over a distance of just 2-3 cells, crossing the plasma membrane in the process. Small uncharged molecules, such as oxygen, carbon dioxide, and water, can diffuse across the plasma membrane on their own. In contrast, ions and larger molecules require the assistance of transport proteins due to their charge or size. Transport across membranes also occurs within individual cells, playing a variety of essential roles for the plant as a whole.
14.4K

